101 related articles for article (PubMed ID: 28183800)
1. TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation.
Yang GL; Zhao Z; Qin TT; Wang D; Chen L; Xiang R; Xi Z; Jiang R; Zhang ZS; Zhang J; Li LY
FASEB J; 2017 May; 31(5):2001-2012. PubMed ID: 28183800
[TBL] [Abstract][Full Text] [Related]
2. TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals.
Zhang K; Cai HX; Gao S; Yang GL; Deng HT; Xu GC; Han J; Zhang QZ; Li LY
Oncotarget; 2016 Oct; 7(43):69436-69449. PubMed ID: 27589684
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
4. Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis.
Xu LX; Grimaldo S; Qi JW; Yang GL; Qin TT; Xiao HY; Xiang R; Xiao Z; Li LY; Zhang ZS
Int J Biochem Cell Biol; 2014 Oct; 55():109-18. PubMed ID: 25161149
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of intracranial hemangioma growth and hemorrhage by TNFSF15.
Yang GL; Han Z; Xiong J; Wang S; Wei H; Qin TT; Xiao H; Liu Y; Xu LX; Qi JW; Zhang ZS; Jiang R; Zhang J; Li LY
FASEB J; 2019 Sep; 33(9):10505-10514. PubMed ID: 31242765
[TBL] [Abstract][Full Text] [Related]
6. Signaling in TNFSF15-mediated Suppression of VEGF Production in Endothelial Cells.
Zhao H; Zhang Q
Methods Mol Biol; 2021; 2248():1-18. PubMed ID: 33185864
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.
Chu LY; Ramakrishnan DP; Silverstein RL
Blood; 2013 Sep; 122(10):1822-32. PubMed ID: 23896411
[TBL] [Abstract][Full Text] [Related]
8. Losartan protects against myocardial ischemia and reperfusion injury
Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK
FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833
[TBL] [Abstract][Full Text] [Related]
9. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
10. Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15.
Yang GL; Li LY
Signal Transduct Target Ther; 2018; 3():21. PubMed ID: 30101034
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.
Xu D; Fuster MM; Lawrence R; Esko JD
J Biol Chem; 2011 Jan; 286(1):737-45. PubMed ID: 20974861
[TBL] [Abstract][Full Text] [Related]
12. Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.
Deng W; Gu X; Lu Y; Gu C; Zheng Y; Zhang Z; Chen L; Yao Z; Li LY
Angiogenesis; 2012 Mar; 15(1):71-85. PubMed ID: 22210436
[TBL] [Abstract][Full Text] [Related]
13. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
Jiang F; Chen Q; Huang L; Wang Y; Zhang Z; Meng X; Liu Y; Mao C; Zheng F; Zhang J; Yan H
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120595
[TBL] [Abstract][Full Text] [Related]
14. TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1.
Qi JW; Qin TT; Xu LX; Zhang K; Yang GL; Li J; Xiao HY; Zhang ZS; Li LY
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13863-8. PubMed ID: 23918400
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the β3 integrin-VEGFR2 complex in Hantaan virus-directed hyperpermeability upon treatment with VEGF.
Wang W; Zhang Y; Li Y; Pan L; Bai L; Zhuang Y; Huang CX; Wang JP; Yu HT; Wei X; Jiang W; Nan YY; Yang DQ; Su WJ; Wang PZ; Bai XF
Arch Virol; 2012 Jun; 157(6):1051-61. PubMed ID: 22407444
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
Kumanishi S; Yamanegi K; Nishiura H; Fujihara Y; Kobayashi K; Nakasho K; Futani H; Yoshiya S
Int J Oncol; 2019 Jul; 55(1):167-178. PubMed ID: 31180533
[TBL] [Abstract][Full Text] [Related]
17. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
18. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway.
Vogel C; Bauer A; Wiesnet M; Preissner KT; Schaper W; Marti HH; Fischer S
J Cell Physiol; 2007 Jul; 212(1):236-43. PubMed ID: 17311300
[TBL] [Abstract][Full Text] [Related]
19. The Bartonella henselae VirB/Bep system interferes with vascular endothelial growth factor (VEGF) signalling in human vascular endothelial cells.
Scheidegger F; Quebatte M; Mistl C; Dehio C
Cell Microbiol; 2011 Mar; 13(3):419-31. PubMed ID: 21044238
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.
Becker PM; Waltenberger J; Yachechko R; Mirzapoiazova T; Sham JS; Lee CG; Elias JA; Verin AD
Circ Res; 2005 Jun; 96(12):1257-65. PubMed ID: 15920019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
